Professor Michael Hubank, scientific director of clinical genomics at the Royal Marsden and professor of translational genomics at the Institute of Cancer Research, London, told the Press Association his team are constantly thinking ahead to how cancer treatment and diagnostics will look in the next three to five years.
Discussion about this post